The Appellate Division has issued a significant published opinion in the ongoing legal battle over the acne drug Accutane. Over 2,000 claims were revived by this decision. If upheld by the New Jersey Supreme Court, the long-term effects of the decision will be even more significant, as it all but eliminates the existing, critical gate-keeping role of trial court judges on admissibility of expert testimony.
A selection of the need-to-know civil justice news for the week of July 29-August 4.
A selection of the need-to-know civil justice news for July 15-28.
Do you remember what you had for lunch yesterday? How about 2 weeks ago? How about 10 years ago? Even if you do remember, do you think you could come up with evidence – like witnesses or receipts – to back up your story, or do we just have to take your word for it?
Some things are changing here at the New Jersey Civil Justice Institute, but one thing will always be the same: our commitment to fighting for a civil justice system that treats all parties fairly and discourages lawsuit abuse.
It has been my pleasure to head up the NJ Civil Justice Institute for the past decade, so it is with some degree of sadness that I write to you today to announce that I will be leaving the NJ Civil Justice Institute at the beginning of August to assume a position as director of public policy at PwC (PricewaterhouseCoopers).
Mark your calendars and plan to join us on October 20 for our annual Fall Legal Reform Conference. This year’s event will be held at Bayer headquarters in Whippany from 8:30AM-1PM.
A tip of our hat to Overlawyered for pointing this out.
A selection of the need-to-know civil justice news for the week of July 8-14.
A selection of the need-to-know civil justice news for the week of July 1-7.
